drugset / Trial / NCT00689039
Study of an Extended Release (ER) Tablet, Single and Repeated Dosing
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose is to study the safety and tolerability of increasing doses of AZD1305 and how the medication is metabolised by the body (how it is taken up, distributed, and how it disappears from the body). The study is performed in healthy volunteers.
Timeline
- Start
- 2007-04
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD1305 | Small molecule | — | Oral |
Indications
No indication recorded.